Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement

British Journal of Cancer

Volumn 77, Issue 9, 1998, Pages 1454-1459

  Butler, L M ^a   Hewett, P J ^a   Butler, W J ^a   Cowled, P A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Apoptosis; Colon cancer; Fas (APO 1 CD95); Gene rearrangement; Loss of heterozygosity

Indexed keywords

DNA; FAS ANTIGEN; RESTRICTION ENDONUCLEASE;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTHERN BLOTTING;

EID: 0031944521     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.239     Document Type: Article

References (40)

1. Abreu-Martin MT, Vidrich A, Lynch DH and Targan SR (1995) Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNFα and ligation of Fas antigen. J Immunol 155: 4147-4154
2. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N and Nagata S (1995) Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genet 11: 294-300
3. Behrmann I, Walezak H and Krammer PH (1994) Structure of the human APO-1 gene. Eur J Immunol 24: 3057-3062
4. Cascino I, Papoff G, De Maria R, Testi R and Ruberti G (1996) Fas/APO-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J Immunol 156: 13-17
5. Cheng J, Liu C, Koopman WJ and Mountz JD (1995) Characterization of human Fas gene. J Immunol 154: 1239-1245
6. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
7. De Maria R, Boirivant M, Cifone MG, Roncaioli P, Hahne M, Tschopp J, Pallone F, Santoni A and Testi R (1996) Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. J Clin Invest 97: 316-322
8. Dhein J, Walezak H, Baumler C, Debatin K-M and Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373: 438-440
9. Drappa J, Vaishnaw AK, Sullivan KE, Chu J-L and Elkon KB (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335: 1643-1649
10. Fearon ER and Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
11. Fiucci G and Ruberti G (1994) Detection of polymorphisms within the FAS cDNA gene sequence by GC-clamp denaturing gradient gel electrophoresis. Immunogenetics 39: 437-439
12. Garewal H, Bernstein H, Bernstein C, Sampliner R and Payne C (1996) Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. Cancer Res 56: 1480-1483
13. Hakuno N, Koji T, Yano T, Kobayashi N, Tsutsumi O, Taketani Y and Nakane PK (1996) Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 137: 1938-1948
14. Hall PA, Coates PJ, Ansari B and Hopwood D (1994) Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 107: 3569-3577
15. Inazawa J, Itoh N, Abe T and Nagata S (1992) Assignment of the human Fas antigen gene (Fas) to 10q24.1. Genomics 14: 821-822
16. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y and Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243
17. Kerr JFR, Winterford CM and Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2026
18. Koetsier PA, Schorr J and Doerfler W (1993) A rapid optimized protocol for downward alkaline Southern blotting of DNA. BioTechniques 15: 260-261
19. Leithauser F, Dhein J, Mechtersheimer G, Koeretz K, Bruderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH and Moller P (1993) Constitutive and induced expression of APO-1. a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 60: 415-429
20. Lichter P, Walczak H, Weitz S, Behrmann I and Krammer PH (1992) The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19. Genomics 14: 179-180.
21. Moller P, Koretz K, Leithauser F, Bruderlein S, Henne C, Quentmeier A and Krammer PH (1994) Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer 57: 371-377
22. Muleris M, Salmon R-J and Dutrillaux B (1990) Cytogenetics of colorectal adenocarcinomas. Cancer Genet Cytogenet 46: 143-156
23. O'Connell J, O'Sullivan GC, Collins JK and Shanahan F (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184: 1071-1082
24. Owen-Schaub LB, Meterissian S and Ford RJ (1993) Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin. J Immunother 14: 234-241
25. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K and Yonehara S (1994) Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res 54: 1580-1586
26. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang W-W, Kruzel E and Radinsky R (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15: 3032-3040
27. Payne CM, Bernstein H and Garewal H (1995) Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis. Ultrastrut Pathol 19: 221-248
28. Peng SL, Robert ME, Hayday AC and Craft J (1996) A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J Exp Med 184: 1149-1154
29. Popescu NC (1994) Chromosome fragility and instability in human cancer. Crit Rev Oncogen 5: 121-140
30. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Dehatin KM, Fischer A and de Villartay JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349
31. 2+-independent T cell-mediated cytotoxicity, J Exp Med 177: 195-200
32. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual. 2n edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
33. Scott N, Martin I, Jack AS, Dixon MF and Quirke P (1996) Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia. J Clin Pathol Mol Pathol 49: M151-M158
34. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ and Levin B (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55: 237-241
35. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin K-M and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-304
36. Vogelstein B, Fearon ER, Kem SE, Hamilton SR, Preisinger AC, Nakamura Y and White R (1989) Allelotype of colorectal carcinomas. Science 244: 207-211
37. Wu J, Zhou T, Zhang J, He J, Gause WC and Mountz JD (1994) Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice, Proc Natl Acad Sci USA 91: 2344-2348
38. Xerri L, Carbuccia N, Parc P and Birg F (1995) Search for rearrangements and/or allelic loss of the fas/APO-1 gene in 101 human lymphomas. Am J Clin Pathol 104: 424-430
39. Yonehara S, Ishii A and Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756
40. Zornig M, Grzeschiczek A, Kowalski M-B, Hartmann K-U and Moroy T (1995) Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in EμL-MYC transgenic mice but not in animals infected with MoMuLV. Oncogene 10: 2397-2401